Drug Shortage Report for MINT-LOSARTAN/HCTZ DS
Report ID | 147790 |
Drug Identification Number | 02389673 |
Brand name | MINT-LOSARTAN/HCTZ DS |
Common or Proper name | losartan Hydrochlorothiazide |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25.0MG 100.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottle |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-21 |
Estimated end date | 2023-03-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-01-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-01-03 | French | Compare |
v5 | 2023-01-03 | English | Compare |
v4 | 2021-10-22 | French | Compare |
v3 | 2021-10-22 | English | Compare |
v2 | 2021-10-21 | French | Compare |
v1 | 2021-10-21 | English | Compare |
Showing 1 to 6 of 6